BioTrove raises $10.9 million

Jan. 29, 2004 — BioTrove Inc. (News, Web), a Woburn, Mass., developer of micro- and nanofluidic technologies, has raised $10.9 million in financing.

null

Catalyst Health and Technology Partners, CB Health Ventures, Zero Stage Capital and BioFrontier Partners participated in the round.

null

The funds will be used to continue development and commercialization of the company’s Living Chip and Momentum Assay.

null

Concurrent with the financing, the company named Ben Bronstein of Zero Stage Capital to its board of directors.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.